REFERENCES
- Efraim L. Healing with animals in the Levant from the 10th to the 18th century. J Ethnobiology Ethnomedicine. 2006;2:11–19.
- Molan PC. The evidence supporting the use of honey as a wound dressing. Int J Low Extrem Wounds. 2006;5:40–54.
- Moore OA, Smith LA, Campbell F, et al. Systematic review of the use of honey as a wound dressing. BMC Complemen Altern Med. 2001;1:2–7.
- Lusby PE, Coombes A, Wilkinson JM, et al. Honey: A potent agent for wound healing? J Wound Ostomy Continence Nurs. 2002;29:295–300.
- Mansour AM. Epithelial corneal oedema treated with honey. Clin Experiment Ophthalmol. 2002;30:149–150.
- Mansour AM, Zein W, Haddad R, et al. Bullous keratopathy treated with honey. Acta Ophthalmol Scand. 2004;82:312–313.
- Albietz JM, Lenton LM. Effect of antibacterial honey on the ocular flora in tear deficiency and meibomian gland disease. Cornea. 2006;25:1012–1019.
- Emarah H. A clinical study of the topical use of bee honey in the treatment of ocular diseases. Bull Islam Med. 1982;2:422–425.
- Golychev VN. [Use of honey in conservative treatment of senile cataract]. Vestn Oftalmol. 1990;106:59–62.
- Mansour AM, Traboulsi E. Honey as a substitute for Healon in experimental anterior segment surgery in animals. Pak J Ophthalmol. 1985;1:136.
- Al-Waili NS. Investigating the antimicrobial activity of natural honey and its effects on the pathogenic bacterial infections of surgical wounds and conjunctiva. J Med Food. 2004;7:210–222.
- Malavazzi GR, Lake JC, Dantas PEC. Effect of honey and autologous serum on corneal epithelial healing in rabbits. Arq Bras Oftalmol. [Online]. 2005;68:347–351.
- Van Setten GB. Vascular endothelial growth factor (VEGF) in normal human corneal epithelium: detection and physiologic importance. Acta Ophthamol Scand. 2007;75:649–652.
- Gan L, Fagerholm P, Palmblad J. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing. Acta Ophthalmol Scand. 2004;82:557–563.
- Phillip W, Speicher L, Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human cornea. Invest Ophthalmol Vis Sci. 2000;41:2514–2522.
- Azar DT. Corneal angiogenic privilege: Angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2006;104:264–302.
- Yoeruek E, Ziemssen F, Henke-Fahle S, et al. Safety, penetration and efficacy of topically applied bevacizumab: Evaluation of eyedrops in corneal neovascularization after chemical burns. Acta Opthalmol. 2008;86:322–328.
- Dastjerdi MH, Al-Arfaj KM, Nallasamy N, et al. Topical bevacizumb in the treatment of corneal neovascularization: Results of a prospective, open-label, noncomparative study. Arch Ophthalmol. 2009;127:381–389.
- Frankel S, Robinson E, Berenbaum R. Antioxidants capacity and correlated charactersitics of 14 unifloral honeys. J Apic Res. 1998;37:27–31.
- Henriques A, Simon J, Cooper R, et al. Free radical production and quenching in honeys with wound healing potential. J Antimicrob Chemother. 2006;58:773–777.
- Al-Waili NS, Boni NS. Natural honey lowers plasma prostaglandin concentrations in normal individuals. J Med Food. 2003;6:129–133.
- Bogdanov S, Jurendic T, Sieber R, et al. Honey for nutrition and health: A review. J Am Coll Nutr. 2008;27:677–689.